CBD is having prominent impact on global markets and regulation, as regulators move to use it as an alternative to traditionally prescribed medications.

Canada made headlines in 2018 after it became the second country in the world to completely legalise adult cannabis use. The country’s Prime Minister Justin Trudeau was a strong advocate for legalisation and ultimately, the country decided to pass new legislation and initiate legal adult-use in late 2018. As more CBD clinical results come out, they are having an impact on regulation around cannabis.

Innocuously tucked inside Canopy Growth Corp.’s cavernous, custom-built bottling facility is a series of four vats which may be the most important pieces of equipment the pot giant owns.

The series of stainless steel containers will each contain more than 300 litres of cannabis resin, the crucial ingredient at the centre of Canopy’s infused beverage plans which it hopes will usher in a new category of spirits and drive in millions of dollars in new revenue.

“Those will contain millions of dollars worth of cannabis soon,” said Mark Zekulin, chief executive officer of Canopy Growth, during a tour of the company’s bottling and chocolate facilities on Tuesday.

Revenue in Canada’s cannabis sector is forecasted to more than double next year despite slower-than-expected growth, according to a leading industry analyst.

Canaccord Genuity analyst Matt Bottomley said in a research note to client that Canada’s cannabis industry should expect $3.16 billion in revenue in 2020, up from the $1.46 billion forecast for 2019.

“As retail dispensaries continue to roll out and new product forms under ‘Cannabis 2.0’ are set to hit the shelves as early as mid-December, we believe the sector will see significant growth in 2020,” Bottomley said.

The legalization of cannabis had an unintended impact on RCMP dogs, who are no longer trained to sniff out cannabis when conducting drug searches.

According to Dog Team Trainer Sergeant Robert Heppell, police dogs that were previously trained on anything marijuana-based, including hash and hash oils, were removed from the program, retired because of age, or were sold to other working agencies that wanted dogs with a marijuana-based narcotics profile.

I'm not sure what's more frightening... the ghouls, goblins, and ghosts you might come across at some point today, or the aggregate return of the cannabis stocks since the end of March. My money might be on the latter, because at least the former winds up with tasty treats by the end of the evening.

In a change that will likely have an even greater effect on the market than legalization of recreational cannabis itself, new drinks and edibles are set to hit Canadian storeshelves in mid-December for people who want to try marijuana, without smoking it.

Tweed opened up it's new production facility on Tuesday, displaying new products including a product called Bakerstreet and ginger ale.

"There's really nothing like this in the world," said Canopy Growth Corporation CEO Mark Zukelin.

There is nothing quite like a migraine. The American Migraine Foundation (AMF) estimates that over 1 billion individuals worldwide suffer from the debilitating pain of migraines. With 1 in 5 women, 1 in 16 men, and 1 in 11 children all dealing with the life-changing effects of migraines, it’s no wonder CBD and marijuana are often brought up as a means of therapy.

According to recent predictions by BDS Analytics, the CBD market will reach somewhere close to $20 billion in sales by the year 2024. That’s a 49 percent compound annual growth rate, a bit shocking for a substance that was almost entirely outlawed less than a decade ago. Here are three profitable trends in the CBD market that entrepreneurs should know about, especially those already building products and companies in the "CannaTech" space.

One year ago, there weren't many investments hotter than cannabis. Our neighbor to the north, Canada, had just launched recreationally legal weed sales two weeks prior (Oct. 17, 2018), and Wall Street's sales estimates for North American cannabis were steadily rising.

But oh, how times have changed.

Despite regulations for Cannabis 2.0 that went into effect two weeks ago, on Oct. 17, Canadian pot stocks have been pummeled for seven consecutive months. However, the bigger issue is that supply constraints in Canada are beginning to be felt at the individual company level.

The month of October has begun to stabilize for pot stocks to some extent. For anyone who watches the industry, they have seen that there has been quite a downtrend in the past few months. This is due to a variety of factors including uncertainty about the future of the industry, and general volatility that seems to be characteristic of pot stocks.